semaglutide and low potassium can cause Best electrolytes for GLP-1: guide to staying balanced on semaglutide tirzepatide Managing Potassium Levels While Using

When Patients Should Contact a Medical Provider Patients should seek medical guidance if they experience: severe nausea or vomiting significant dizziness allergic-type reactions worsening symptoms unusual swelling persistent headaches concerning injection site reactions Peptide therapy should never replace emergency medical care

Maximum 8 doses per month, with at least 24 hours between doses

GLP-1 receptor agonists work by: Stimulating insulin secretion from pancreatic beta cells in a glucose-dependent manner Suppressing glucagon release when blood glucose levels are elevated Slowing gastric emptying, which moderates post-meal glucose rises (this effect may attenuate over time) Reducing appetite through effects on brain centres controlling satiety Understanding this pharmacological profile is essential when considering the hypoglycaemic potential of Wegovy

The key is training smarter, not harder, within your reduced recovery capacity